Evidence map›Paper›PMID 25232856›Full record

Trial reportGenetics in medicine : official journal of the American College of Medical Genetics2015

Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling.

Morgan Butrick, Scott Kelly, Beth N Peshkin, George Luta, Rachel Nusbaum, Gillian W Hooker, Kristi Graves, Lisa Feeley, Claudine Isaacs, Heiddis B Valdimarsdottir and 7 more

Open access · hybridAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Genetics in medicine : official journal of the American College of Medical Genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 4 pooled it
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 4 syntheses or guidelines pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Virtual Care in Patients with Cancer: A Systematic Review.Current oncology (Toronto, Ont.) · 2021
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. The Genetic Education for Men (GEM) Trial: Development of Web-Based Education for Untested Men in BRCA1/2-Positive Families.Journal of cancer education : the official journal of the American Association for Cancer Education · 2021
    Trial
  9. Trial
  10. Genetic Testing in a Population-Based Sample of Breast and Ovarian Cancer Survivors from the REACH Randomized Trial: Cost Barriers and Moderators of Counseling Mode.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2017
    Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Transforming patient-centered cancer care using telehealth: the MATCHES Center.Journal of the National Cancer Institute. Monographs · 2024
    Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Morgan ButrickLaboratory of Immunology, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA.
Scott KellyDepartment of Oncology, Cancer Prevention and Control Program and Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.ORCID 0000000203751040
Beth N PeshkinDepartment of Oncology, Cancer Prevention and Control Program and Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
George LutaDepartment of Biostatistics, Bioinformatics, and Biomathematics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Rachel NusbaumDepartment of Oncology, Cancer Prevention and Control Program and Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Gillian W HookerSocial and Behavioral Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
Kristi GravesDepartment of Oncology, Cancer Prevention and Control Program and Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Lisa FeeleyDepartment of Oncology, Cancer Prevention and Control Program and Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Claudine IsaacsDepartment of Oncology, Cancer Prevention and Control Program and Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Heiddis B ValdimarsdottirDepartment of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Lina JandorfDepartment of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Tiffani DeMarcoDepartment of Oncology, Cancer Prevention and Control Program and Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Marie WoodFamilial Cancer Program of the Vermont Cancer Center, University of Vermont College of Medicine, Burlington, Vermont, USA.
Wendy McKinnonFamilial Cancer Program of the Vermont Cancer Center, University of Vermont College of Medicine, Burlington, Vermont, USA.
Judy GarberCenter for Cancer Genetics and Prevention, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
Shelley R McCormickCenter for Cancer Genetics and Prevention, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
Marc D SchwartzDepartment of Oncology, Cancer Prevention and Control Program and Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Georgetown University · USHarvard University · USIcahn School of Medicine at Mount Sinai · USNational Institutes of Health · USUniversity of Vermont · US

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI STEPHEN W BYERS · 1990 to 2026
$71.5M
Telephone-Based Genetic Counseling: An Equivalence TrialR01CA108933 · NCI · GEORGETOWN UNIVERSITY · PI SCHWARTZ, MARC D · 2004 to 2008
$2.3M
Intramural NIH HHS Z99 AI999999NCI NIH HHS P30 CA051008NCI NIH HHS R01 CA108933
6 · The paper itself

Abstract

purposeAs genetic counseling and testing become more fully integrated into clinical care, alternative delivery models are increasingly prominent. This study examines predictors of genetic testing for hereditary breast/ovarian cancer among high-risk women in a randomized trial of in-person versus telephone-based genetic counseling.

methodsMethods include multivariable logistic regression and interaction analyses.

resultsOf the 669 participants, 600 completed counseling and 523 received test results. As previously reported, participants randomized to telephone counseling were significantly less likely to be tested. In intention-to-treat analyses, completion of counseling and testing was associated with: race/ethnicity (odds ratio (OR) = 1.96, 95% confidence interval (CI): 1.20-3.20), perceived stress (OR = 0.89, 95% CI: 0.81-0.98), knowledge (OR = 1.12, 95% CI: 1.02-1.23), and randomization group (OR = 1.48, 95% CI: 1.01-2.16). Further, race/ethnicity moderated the association between randomization group and testing; minority women receiving telephone counseling were least likely to complete testing.

conclusionEvidence for logistical and communication-based explanations for this interaction is presented. The overall increased access made possible with telephone genetic counseling should be considered in light of the possibility that this may also lead to lower rates of testing among high-risk minority women. Additional care should be taken to assess and address potential barriers when services are delivered by telephone.Genet Med 17 6, 467-475.

Indexed as

Genes, BRCA1Genes, BRCA2Genetic CounselingGenetic TestingHealthcare DisparitiesAdultFemaleHereditary Breast and Ovarian Cancer SyndromeHumansMiddle AgedOdds RatioRisk FactorsTelephone

Identifiers

PMID25232856
PMCPMC4364924
OpenAlexW1989432584

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.